Remdesivir therapy for severe pediatric COVID-19 in Singapore: a single-center retrospective observational cohort study

Remdesivir therapy for severe pediatric COVID-19 in Singapore: a single-center retrospective observational cohort study

There is a paucity of information on remdesivir (RDV) use in severe pediatric coronavirus disease 2019 (COVID-19). We aimed to explore the effectiveness of RDV as the cumulative proportion of pediatric COVID-19 patients deescalated from Day 5 of high dependency or intensive care unit (HD/ICU).

Bibliográfalaš dieđut
Váldodahkkit: Seah, Valerie Xue Fen, Ong, Rina Yue Ling, Kam, Kai-Qian, Thoon, Koh Cheng, Tan, Natalie Woon Hui, Li, Jiahui, Nadua, Karen Donceras, Chong, Chia Yin, Yung, Chee Fu
Eará dahkkit: Lee Kong Chian School of Medicine (LKCMedicine)
Materiálatiipa: Journal Article
Giella:English
Almmustuhtton: 2024
Fáttát:
Medicine, Health and Life Sciences
Children
Pediatric
Liŋkkat:https://hdl.handle.net/10356/173749

Interneahtta

https://hdl.handle.net/10356/173749

Geahča maid